Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach-Reference-Cited by-同舟云学术

Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

Published:2013-01 Issue:1 Volume:19 Page:69-74
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Blanes Margarita,Lahuerta Juan J.,González José D.,Ribas Paz,Solano Carlos,Alegre Adrían,Bladé Joan,San Miguel Jesús F.,Sanz Miguel A.,de la Rubia Javier

Funder

“Red Temática de Investigación Cooperativa en Cancer”

“Red de Biobancos Hospitalarios”

“Instituto de Salud Carlos III”

“Ministerio de Ciencia e Innovación”

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Autologous transplantation for multiple myeloma;Harousseau;Ann Oncol,2008

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome;Attal;N Engl J Med,1996